BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA

BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA

The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3ɛ (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma.. La invención hace referencia a un anticuerpo biespecifico que se une de forma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jesús Fernando SAN MIGUEL IZQUIERDO, Klaus STREIN, Minh Diem VU, Bruno David Lourenço PAIVA
Format: Patent
Sprache:eng ; spa
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Jesús Fernando SAN MIGUEL IZQUIERDO
Klaus STREIN
Minh Diem VU
Bruno David Lourenço PAIVA
description The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3ɛ (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma.. La invención hace referencia a un anticuerpo biespecifico que se une de forma específica al antígeno de maduración de linfocitos B (BCMA) humano y al CD3e (CD3) humano, junto con un fármaco inmunoterapeutico para uso combinado en el tratamiento del mieloma múltiple.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2019004621A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2019004621A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2019004621A3</originalsourceid><addsrcrecordid>eNqNyssKwjAQQNFuXIj6D4N7oQ8Rupw8GgcySWkTsKtSJK5EC_X_UcQPcHXgctfZLKhvtaSGJKALJLwaAA2S6wMIyfipCqSqvqIDYo7OW29IogXVRQON70B6FuS0gthrIAeh0xjIGeBoA7VWAw_aesZttrpN9yXtfm6yfaODPB_S_BzTMk_X9EivkS9lXtR5fjyVBVZ_TW_M8DeT</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA</title><source>esp@cenet</source><creator>Jesús Fernando SAN MIGUEL IZQUIERDO ; Klaus STREIN ; Minh Diem VU ; Bruno David Lourenço PAIVA</creator><creatorcontrib>Jesús Fernando SAN MIGUEL IZQUIERDO ; Klaus STREIN ; Minh Diem VU ; Bruno David Lourenço PAIVA</creatorcontrib><description>The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3ɛ (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma.. La invención hace referencia a un anticuerpo biespecifico que se une de forma específica al antígeno de maduración de linfocitos B (BCMA) humano y al CD3e (CD3) humano, junto con un fármaco inmunoterapeutico para uso combinado en el tratamiento del mieloma múltiple.</description><language>eng ; spa</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20191128&amp;DB=EPODOC&amp;CC=MX&amp;NR=2019004621A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20191128&amp;DB=EPODOC&amp;CC=MX&amp;NR=2019004621A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Jesús Fernando SAN MIGUEL IZQUIERDO</creatorcontrib><creatorcontrib>Klaus STREIN</creatorcontrib><creatorcontrib>Minh Diem VU</creatorcontrib><creatorcontrib>Bruno David Lourenço PAIVA</creatorcontrib><title>BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA</title><description>The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3ɛ (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma.. La invención hace referencia a un anticuerpo biespecifico que se une de forma específica al antígeno de maduración de linfocitos B (BCMA) humano y al CD3e (CD3) humano, junto con un fármaco inmunoterapeutico para uso combinado en el tratamiento del mieloma múltiple.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyssKwjAQQNFuXIj6D4N7oQ8Rupw8GgcySWkTsKtSJK5EC_X_UcQPcHXgctfZLKhvtaSGJKALJLwaAA2S6wMIyfipCqSqvqIDYo7OW29IogXVRQON70B6FuS0gthrIAeh0xjIGeBoA7VWAw_aesZttrpN9yXtfm6yfaODPB_S_BzTMk_X9EivkS9lXtR5fjyVBVZ_TW_M8DeT</recordid><startdate>20191128</startdate><enddate>20191128</enddate><creator>Jesús Fernando SAN MIGUEL IZQUIERDO</creator><creator>Klaus STREIN</creator><creator>Minh Diem VU</creator><creator>Bruno David Lourenço PAIVA</creator><scope>EVB</scope></search><sort><creationdate>20191128</creationdate><title>BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA</title><author>Jesús Fernando SAN MIGUEL IZQUIERDO ; Klaus STREIN ; Minh Diem VU ; Bruno David Lourenço PAIVA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2019004621A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Jesús Fernando SAN MIGUEL IZQUIERDO</creatorcontrib><creatorcontrib>Klaus STREIN</creatorcontrib><creatorcontrib>Minh Diem VU</creatorcontrib><creatorcontrib>Bruno David Lourenço PAIVA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Jesús Fernando SAN MIGUEL IZQUIERDO</au><au>Klaus STREIN</au><au>Minh Diem VU</au><au>Bruno David Lourenço PAIVA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA</title><date>2019-11-28</date><risdate>2019</risdate><abstract>The invention relates to a bispecific antibody specifically binding to human B cell maturation antigen (BCMA) and to human CD3ɛ (CD3) together with an immunotherapeutic drug for combined use in treating multiple myeloma.. La invención hace referencia a un anticuerpo biespecifico que se une de forma específica al antígeno de maduración de linfocitos B (BCMA) humano y al CD3e (CD3) humano, junto con un fármaco inmunoterapeutico para uso combinado en el tratamiento del mieloma múltiple.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_MX2019004621A
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T08%3A37%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Jes%C3%BAs%20Fernando%20SAN%20MIGUEL%20IZQUIERDO&rft.date=2019-11-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2019004621A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true